IDEAS home Printed from https://ideas.repec.org/p/lee/wpaper/1407.html
   My bibliography  Save this paper

Life at a premium: considering an end-of-life premium in Value Based Reimbursement

Author

Listed:
  • Christopher McCabe

    (Department of Emergency Medicine, University of Alberta, University Terrace, 8303 112th St. Edmonton, Alberta, Canada.)

  • Mike Paulden

    (Department of Emergency Medicine, University of Alberta, University Terrace, 8303 112th St. Edmonton, Alberta, Canada.)

  • James O'Mahony

    (Trinity College Dublin, Ireland)

  • Richard Edlin

    (Health Systems, School of Population Health, University of Auckland)

  • Anthony Culyer

    (Centre for Health Economics, University of York, UK. Institute of Health Policy, Management and Evaluation, University of Toronto, Canada.)

Abstract

The increasingly explicit use of health technology assessment continues to generate substantial public and academic policy debates. The debates are about puzzling issues whose correct resolution is not immediately obvious and the very explicitness of HTA’s use pinpoints the issues and locates those likely to gain or lose from the solutions. The application of an end-of-life premium is one of a number of proposed ‘values’ for affecting who wins and who loses from HTA and reimbursement processes. In this chapter we review the literature on value premiums generally and the end of life premium specifically, before describing a conceptual framework for coherent use of value premiums in reimbursement decision process and how an end-of-life premium might work.

Suggested Citation

  • Christopher McCabe & Mike Paulden & James O'Mahony & Richard Edlin & Anthony Culyer, 2014. "Life at a premium: considering an end-of-life premium in Value Based Reimbursement," Working Papers 1407, Academic Unit of Health Economics, Leeds Institute of Health Sciences, University of Leeds.
    • Handle: RePEc:lee:wpaper:1407
    as

    Download full text from publisher

    File URL: http://medhealth.leeds.ac.uk/download/1102/auhe_wp14_07
    File Function: First version, 2014
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Banta, David, 2003. "The development of health technology assessment," Health Policy, Elsevier, vol. 63(2), pages 121-132, February.
    Full references (including those not matched with items on IDEAS)

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Wang, Yi & Rattanavipapong, Waranya & Teerawattananon, Yot, 2021. "Using health technology assessment to set priority, inform target product profiles, and design clinical study for health innovation," Technological Forecasting and Social Change, Elsevier, vol. 172(C).
    2. Velasco Garrido, Marcial & Gerhardus, Ansgar & Røttingen, John-Arne & Busse, Reinhard, 2010. "Developing Health Technology Assessment to address health care system needs," Health Policy, Elsevier, vol. 94(3), pages 196-202, March.
    3. Cyr, Pascale Renée & Jain, Vageesh & Chalkidou, Kalipso & Ottersen, Trygve & Gopinathan, Unni, 2021. "Evaluations of public health interventions produced by health technology assessment agencies: A mapping review and analysis by type and evidence content," Health Policy, Elsevier, vol. 125(8), pages 1054-1064.
    4. A. Chapman & C. Taylor & A. Girling, 2014. "Are the UK Systems of Innovation and Evaluation of Medical Devices Compatible? The Role of NICE’s Medical Technologies Evaluation Programme (MTEP)," Applied Health Economics and Health Policy, Springer, vol. 12(4), pages 347-357, August.
    5. Bombard, Yvonne & Abelson, Julia & Simeonov, Dorina & Gauvin, Francois-Pierre, 2011. "Eliciting ethical and social values in health technology assessment: A participatory approach," Social Science & Medicine, Elsevier, vol. 73(1), pages 135-144, July.
    6. Elena Nicod, 2017. "Why do health technology assessment coverage recommendations for the same drugs differ across settings? Applying a mixed methods framework to systematically compare orphan drug decisions in four Europ," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 18(6), pages 715-730, July.
    7. Francesca Iandolo & Pietro Vito & Irene Fulco & Francesca Loia, 2018. "From Health Technology Assessment to Health Technology Sustainability," Sustainability, MDPI, vol. 10(12), pages 1-22, December.
    8. Hartz, Susanne & John, Jürgen, 2009. "Public health policy decisions on medical innovations: What role can early economic evaluation play?," Health Policy, Elsevier, vol. 89(2), pages 184-192, February.
    9. Lopes, Edilene & Carter, Drew & Street, Jackie, 2015. "Power relations and contrasting conceptions of evidence in patient-involvement processes used to inform health funding decisions in Australia," Social Science & Medicine, Elsevier, vol. 135(C), pages 84-91.
    10. Milena Vainieri & Francesca Ferrè & Stefania Manetti, 2021. "An Integrated Framework to Measure the Performance of Inter-Organizational Programme on Health Technology Assessment," Sustainability, MDPI, vol. 13(7), pages 1-17, March.
    11. Gabriele Palozzi & Sandro Brunelli & Camilla Falivena, 2018. "Higher Sustainability and Lower Opportunistic Behaviour in Healthcare: A New Framework for Performing Hospital-Based Health Technology Assessment," Sustainability, MDPI, vol. 10(10), pages 1-19, October.
    12. Livio Garattini & Anna Padula, 2020. "HTA for pharmaceuticals in Europe: will the mountain deliver a mouse?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(1), pages 1-5, February.
    13. repec:bla:glopol:v:8:y:2017:i::p:97-102 is not listed on IDEAS
    14. Fanni Rencz & Gábor Ruzsa & Alex Bató & Zhihao Yang & Aureliano Paolo Finch & Valentin Brodszky, 2022. "Value Set for the EQ-5D-Y-3L in Hungary," PharmacoEconomics, Springer, vol. 40(2), pages 205-215, December.
    15. Nicod, Elena & Kanavos, Panos, 2016. "Developing an evidence-based methodological framework to systematically compare HTA coverage decisions: A mixed methods study," Health Policy, Elsevier, vol. 120(1), pages 35-45.
    16. Fontrier, Anna-Maria & Visintin, Erica & Kanavos, Panos, 2022. "Similarities and differences in Health Technology Assessment systems and implications for coverage decisions: evidence from 32 countries," LSE Research Online Documents on Economics 112969, London School of Economics and Political Science, LSE Library.
    17. Alberto Manelli & Oscar Domenichelli & Roberta Pace & Martina Vallesi, 2016. "HTA in the nutritional care: investments? efficiency and effectiveness," RIVISTA DI STUDI SULLA SOSTENIBILITA', FrancoAngeli Editore, vol. 2016(2), pages 57-68.
    18. John Bridges, 2006. "Lean Systems Approaches to Health Technology Assessment," PharmacoEconomics, Springer, vol. 24(2), pages 101-109, December.
    19. Ciani, Oriana & Tarricone, Rosanna & Torbica, Aleksandra, 2012. "Diffusion and use of health technology assessment in policy making: What lessons for decentralised healthcare systems?," Health Policy, Elsevier, vol. 108(2), pages 194-202.
    20. Belfiore, Alessandra & Scaletti, Alessandro & Lavorato, Domenica & Cuccurullo, Corrado, 2023. "The long process by which HTA became a paradigm: A longitudinal conceptual structure analysis," Health Policy, Elsevier, vol. 127(C), pages 74-79.
    21. Ani Matei & Adrian-Stelian Dumitru & Corina-Georgiana Antonovici, 2021. "The EU Health Technology Assessment and the Open Method of Coordination: A Relation with Potential in the Context of Network Governance," Sustainability, MDPI, vol. 13(6), pages 1-22, March.

    More about this item

    Keywords

    end-of-life; Health Technology Assessment;

    JEL classification:

    • I10 - Health, Education, and Welfare - - Health - - - General
    • I12 - Health, Education, and Welfare - - Health - - - Health Behavior
    • I14 - Health, Education, and Welfare - - Health - - - Health and Inequality
    • I18 - Health, Education, and Welfare - - Health - - - Government Policy; Regulation; Public Health

    Statistics

    Access and download statistics

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:lee:wpaper:1407. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Judy Wright (email available below). General contact details of provider: https://edirc.repec.org/data/heleeuk.html .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.